← Back to directory

Christopher C. Rowe

Researcher Next ID · RN-027820

Researcher · Medicine

Florey Institute of Neuroscience and Mental Health

Melbourne, Australia

Not currently recruitingFunding unknown
Works count
943
Citation count
65,844
H-index
101
i10-index
322

Research interests

Medicine
Neuroscience
Dementia and Cognitive Impairment Research
Alzheimer's disease research and treatments
Medical Imaging Techniques and Applications
Functional Brain Connectivity Studies
Advanced Neuroimaging Techniques and Applications

Publications

  • Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

    JAMA Neurology · 2024 · 10.1001/jamaneurol.2024.3770

  • Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

    Nature Medicine · 2022 · 10.1038/s41591-022-02049-x

  • Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

    The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00066-1

  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease

    Nature · 2018 · https://doi.org/10.1038/nature25456

  • NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

    Alzheimer s & Dementia · 2018 · https://doi.org/10.1016/j.jalz.2018.02.018

  • Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

    Nature Reviews Neurology · 2018 · 10.1038/nrneurol.2018.9

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

    Alzheimer s & Dementia · 2016 · https://doi.org/10.1016/j.jalz.2016.02.002

  • Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Alzheimer s & Dementia · 2015 · 10.1016/j.jalz.2015.02.004

  • Alzheimer's disease

    Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.56

  • Prevalence of Amyloid PET Positivity in Dementia Syndromes

    JAMA · 2015 · https://doi.org/10.1001/jama.2015.4669

  • The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

    Alzheimer s & Dementia · 2014 · 10.1016/j.jalz.2014.07.003

  • Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment

    Molecular Psychiatry · 2014 · 10.1038/mp.2014.127

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70090-0

  • Tau imaging: early progress and future directions

    The Lancet Neurology · 2014 · 10.1016/s1474-4422(14)70252-2

  • Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

    Alzheimer s & Dementia · 2013 · 10.1016/j.jalz.2013.01.002

  • Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin

    Diabetes Care · 2013 · 10.2337/dc13-0229

  • Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

    The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(13)70044-9

  • Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

    Proceedings of the National Academy of Sciences · 2013 · 10.1073/pnas.1317918110

  • Amyloid Imaging with18F-Florbetaben in Alzheimer Disease and Other Dementias

    Journal of Nuclear Medicine · 2011 · 10.2967/jnumed.111.089730

  • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    Alzheimer s & Dementia · 2011 · https://doi.org/10.1016/j.jalz.2011.03.003

  • Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

    Annals of Neurology · 2011 · 10.1002/ana.22248

  • Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

    Neurobiology of Aging · 2010 · 10.1016/j.neurobiolaging.2010.04.007

  • Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

    Journal of Neurology Neurosurgery & Psychiatry · 2008 · 10.1136/jnnp.2007.127878

  • Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

    The Lancet Neurology · 2008 · 10.1016/s1474-4422(08)70001-2

  • Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation

    European Respiratory Journal · 1994 · 10.1183/09031936.94.07112016

Current projects

    No projects listed.